Concomitant Hydroxyurea, 5‐Fluorouracil, and Radiation Therapy for Recurrent Head and Neck Cancer: Early Results
Authors:
- 1 April 1988
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 98 (4) , 295-298
Abstract
We tested the combination of hydroxyurea (HU), 5‐fluorouracil (5‐FU), and concomitant radiotherapy (XRT) in a group of patients with advanced or recurrent head and neck cancer. Both drugs are effective single agents, have shown synergistic activity in vitro, and can act as radiation sensitizers. A 5‐day course of radiotherapy, with simultaneous HU and continuous infusion 5‐FU, was followed by a 9‐day rest period; cycles were repeated until completion of XRT. Sixteen patients have completed their therapy. Eleven patients had recurrent disease after previous therapy with surgery (11 patients), radiotherapy (9 patients), and combination chemotherapy (4 patients). Five patients had not received previous local therapy. These patients had persistent disease after induction chemotherapy and/or were inoperable because of poor general medical condition. Of 15 patients evaluable for response, 9 had complete response, including 5 patients who had earlier local therapy; 5 had partial response; and 1 failed to respond. Toxicities included mild myelosuppression and mucositis. No unusual complication related to previous radiotherapy was observed. This regimen has shown impressive activity in a cohort of patients who are not usually responsive to other types of currently available therapy. We are continuing our investigation to further define efficacy, toxicity, and maximally tolerated doses of this regimen.Keywords
This publication has 13 references indexed in Scilit:
- Nonoperative therapy for squamous-cell cancer of the esophagus.Journal of Clinical Oncology, 1987
- Simultaneous Cisplatin Fluorouracil Infusion and Radiation Followed by Surgical Resection in Regionally Localized Stage III, Non–Small Cell Lung CancerThe Annals of Thoracic Surgery, 1987
- Phase I and II trial of five-day infused 5-fluorouracil and radiation in advanced cancer of the head and neck.Journal of Clinical Oncology, 1984
- Hydroxyurea: A radiation potentiator in carcinoma of the uterine cervixAmerican Journal of Obstetrics and Gynecology, 1983
- Chemotherapy in Head and Neck CancerNew England Journal of Medicine, 1983
- Changing role of chemotherapy in treatment of head and neck cancerThe American Journal of Medicine, 1982
- Therapeutic response of leukemic mice treated with fluorinated pyrimidines and inhibitors of deoxyuridylate synthesisBiochemical Pharmacology, 1982
- A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancerCancer, 1981
- Clinical use of radiation sensitizing agentsCancer Treatment Reviews, 1974
- Treatment of advanced cancer of the head and neckCancer, 1970